Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J Zyrtec Pediatric Spoon Marks Increased Role For Dosing Innovations

This article was originally published in The Tan Sheet

Executive Summary

Johnson & Johnson's introduction of pre-dosed spoons of children's Zyrtec reflects the growing attention the OTC market is paying to innovative solutions to dosing and safety issues -- particularly for pediatric populations
Advertisement

Related Content

Dosing Device Paradigm Shifts For Liquid OTCs In Wake Of Safety Concerns
Dosing Device Paradigm Shifts For Liquid OTCs In Wake Of Safety Concerns
Dosing Device Paradigm Shifts For Liquid OTCs In Wake Of Safety Concerns
Claritin, Zyrtec And Visine Products Flood Eye Drop Market
Claritin, Zyrtec And Visine Products Flood Eye Drop Market
Study raises pediatric dosing concerns
Zyrtec Model Shows Managed Care’s “Softer” Side For Switching Patients
Data Support Phenylephrine Efficacy, But More Studies Needed – NDAC
Standardize Wording, Dosing Devices of Pediatric Cold Products – NDAC
Standardize Wording, Dosing Devices of Pediatric Cold Products – NDAC

Topics

Advertisement
UsernamePublicRestriction

Register

PS103187

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel